Rulemaking action by the Iowa Board of Pharmacy has been published in the Iowa Administrative Bulletin as follows:
Notice of Intended Action
ARC 5113C has been published as a Notice of Intended Action to amend:
-
Chapter 1, “Purpose and Organization,”
-
Chapter 2, “Pharmacist Licenses,”
-
Chapter 8, “Universal Practice Standards,”
-
Chapter 13, “Telepharmacy Practice,”
-
Chapter 16, “Nuclear Pharmacy Practice,”
-
Chapter 26, “Petitions for Rule Making,”
-
Chapter 34, “Rules for Waivers and Variances,” and
-
Chapter 39, “Expanded Practice Standards.”
-
The proposed amendments bring the Board’s rules in alignment with Iowa Code changes made during the 2019 and 2020 legislative sessions and include:
-
Oversight of the Board’s Executive Director (2019 Iowa Acts, House File 766),
-
Service animals or service-animals-in-training (2019 Iowa Acts, Senate File 341),
-
Extension of the repeal date of the authorization for physician-signed immunization protocols (2020 Iowa Acts, House File 2627),
-
Waivers and variances (2020 Iowa Acts, House File 2389), and
-
Submission of the disposition of a petition for rule making to the Administrative Rules Review Committee (2020 Iowa Acts, House File 2389).
-
-
Comments may be submitted no later than 4:30pm on August 18, 2020.
ARC 5114C has been published as a Notice of Intended Action to amend Chapter 10, “Controlled Substances,” and Chapter 11, “Drugs in Emergency Medical Service Programs.”
-
The proposed amendments:
-
Clarify the expectation that a registrant’s perpetual inventory must at all times accurately reflect the actual on-hand inventory of the substances, and
-
Simplify the rule relating to the purchase of Schedule I and II substances in response to amendments to federal regulations allowing a new single page DEA Form 222 while still allowing use of the triplicate form for a period of time.
-
-
Comments may be submitted no later than 4:30pm on August 18, 2020.
ARC 5115C has published as a Notice of Intended Action to amend Chapter 8, “Universal Practice Standards” and Chapter 21, “Electronic Data and Automated Systems in Pharmacy Practice.”
-
The proposed amendments clarify that patient information which is needed for a pharmacist to conduct drug utilization review must be obtained and that the collection of that information can be delegated to a pharmacy technician. The amendments also include that an electronically transmitted prescription must include the telephone number at which the prescriber can be contacted. The amendments also update a reference.
-
Comments may be submitted no later than 4:30pm on August 18, 2020.